Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases

Abstract In case of AAV with kidney involvement, physicians should explore anti‐GBM antibodies and be aware of the possible sequential development of AAV, especially with MPO‐ANCA, and anti‐GBM glomerulonephritis. This sequential disease history is associated with a poor renal outcome, highlighting...

Полное описание

Библиографические подробности
Главные авторы:	Camille Le Moine, Noémie Jourde‐Chiche, Delphine Kemlin, Benjamin Terrier, Frédéric Vandergheynst
Формат:	Статья
Язык:	English
Опубликовано:	Wiley 2021-07-01
Серии:	Clinical Case Reports
Предметы:	ANCA‐associated vasculitis anti‐GBM disease glomerulonephritis myeloperoxidase
Online-ссылка:	https://doi.org/10.1002/ccr3.4553

Схожие документы

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
по: N M Bulanov, и др.
Опубликовано: (2018-06-01)

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients
по: Xueling Hu, и др.
Опубликовано: (2022-10-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
по: Precil Diego Miranda de Menezes Neves, и др.
Опубликовано: (2021-08-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
по: Valentine Gillion, и др.
Опубликовано: (2017-03-01)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
по: Afroditi Maria Konstantouli, и др.
Опубликовано: (2022-09-01)

Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report
по: Takuya Yamazaki, и др.
Опубликовано: (2023-07-01)

Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA
по: Florian Garo, и др.
Опубликовано: (2022-04-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
по: Ana Teresa Domingos, и др.
Опубликовано: (2019-10-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
по: Naohiro Yoshida, и др.
Опубликовано: (2014-01-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
по: Adam D. Morris, и др.
Опубликовано: (2022-04-01)

Three Diseases Mediated by Different Immunopathologic Mechanisms—ANCA-Associated Vasculitis, Anti-Glomerular Basement Membrane Disease, and Immune Complex-Mediated Glomerulonephritis—A Common Clinical and Histopathologic Picture: Rapidly Progressive Crescentic Glomerulonephritis
по: Cristina Gluhovschi, и др.
Опубликовано: (2023-11-01)

An unusual cause of rapidly progressive glomerulonephritis associated with ANCA vasculitis and ovarian malignancy – a relapse 39 years after initial treatment
по: Nikola Simovic, и др.
Опубликовано: (2023-07-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
по: D. Bele, и др.
Опубликовано: (2020-01-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
по: Désirée Tampe, и др.
Опубликовано: (2021-09-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
по: Rui Wu, и др.
Опубликовано: (2021-03-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
по: Dario Roccatello, и др.
Опубликовано: (2022-03-01)

Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival
по: Wei Lin, и др.
Опубликовано: (2021-03-01)

Complement Inhibition in ANCA-Associated Vasculitis
по: Vladimir Tesar, и др.
Опубликовано: (2022-07-01)

ANCA-Associated Vasculitis May Result as a Complication to Both SARS-CoV-2 Infection and Vaccination
по: Michalis Christodoulou, и др.
Опубликовано: (2022-07-01)

Treatment of renal manifestations of ANCA-associated vasculitis
по: Kresimir Galesic, и др.
Опубликовано: (2013-01-01)

Environmental factors influencing the risk of ANCA-associated vasculitis
по: Wen-Man Zhao, и др.
Опубликовано: (2022-09-01)

Presentation and progression of MPO-ANCA interstitial lung disease
по: Lorenzo Salvati, и др.
Опубликовано: (2024-06-01)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
по: Samy Hakroush, и др.
Опубликовано: (2021-10-01)

Clinical Phenotype and Outcomes of Indo-Asian Patients with ANCA-Associated Glomerulonephritis in the North West, UK
по: Lauren Floyd, и др.
Опубликовано: (2023-11-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
по: Nankee K. Kumar, AB, и др.
Опубликовано: (2024-03-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
по: A. V. Burlutskaya, и др.
Опубликовано: (2020-10-01)

A case of COVID‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy
по: Michael Filoramo, и др.
Опубликовано: (2024-08-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
по: Kazuhiro Kitamoto, и др.
Опубликовано: (2023-08-01)

Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
по: Zhonghua Liao, и др.
Опубликовано: (2021-07-01)

Update of Management of ANCA-Associated Vasculitis
по: Hoi San Tang, и др.
Опубликовано: (2021-12-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
по: Marinchev Liubomir, и др.
Опубликовано: (2013-10-01)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
по: Aglaia Chalkia, и др.
Опубликовано: (2020-01-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
по: Zachary S. Wallace, и др.
Опубликовано: (2019-12-01)

Rapidly progressive glomerulonephritis and ANCA-negative pauci-immune vasculitis: an unusual presentation. A case report
по: Zitlali Guadalupe Paulín Zepeda, и др.
Опубликовано: (2023-09-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
по: Charmaine van Eeden, и др.
Опубликовано: (2023-04-01)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
по: Laura S. van Dam, и др.
Опубликовано: (2020-12-01)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
по: Claire Harris, и др.
Опубликовано: (2018-06-01)

Impact of ANCA-Associated Vasculitis on Outcomes of Hospitalizations for Goodpasture’s Syndrome in the United States: Nationwide Inpatient Sample 2003–2014
по: Charat Thongprayoon, и др.
Опубликовано: (2020-03-01)

ANCA-associated Leucocytoclastic Vasculitis presenting with Bronchiectasis, GI Involvement and Hypertensive Urgency: A Complex Case without Renal Involvement
по: N. M. M. Risly, и др.
Опубликовано: (2024-12-01)

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population: a genetic association study
по: Aya Kawasaki, и др.
Опубликовано: (2020-10-01)